by Alyssa Lee | Apr 30, 2026
Selected as a participating site network for a Phase 3 Pneumococcal Vaccine trial, DelRicht Research was entrusted with enrolling healthy, pneumococcal-naïve adults across two specialized sites. From challenges including strict “pneumococcal-naïve”...
by Alyssa Lee | Mar 19, 2026
DelRicht Research is proud to highlight the performance of its multi-site network in a U.S.-based Phase 3b/4 COVID-19 booster vaccine trial, where speed, coordination, and adaptability were critical to success. Exclusively selected as the site network for this study,...
by Alyssa Lee | Nov 13, 2025
DelRicht Research is proud to highlight the outstanding performance of our site teams across Atlanta, Gulfport, New Orleans, and Tulsa in a recent Phase 3 clinical trial for migraine. Designed to evaluate the safety and efficacy of an investigational therapy in adults...
by Alyssa Lee | Oct 31, 2025
DelRicht Research is proud to highlight the outstanding performance of Dr. Patrick Dennis and the New Orleans site team at Touro Medical Center in a recent Phase 2 clinical trial evaluating an investigational therapy for adults with uncontrolled hypertension. The...
by Alyssa Lee | Oct 23, 2025
DelRicht Research is proud to highlight the outstanding performance of our dermatology teams in a recent Phase 2 clinical trial for hidradenitis suppurativa (HS), a chronic and often painful inflammatory skin condition that impacts quality of life for patients...
